← Leaderboards
Edward Kenneth Rodriguez
Beth Israel Deaconess Medical Center
$719,329
Attributed
$2,541,560
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $576K · FY2012–20$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,541,560 · 3
By mechanism
R01$1,534,289 · 1
R56$575,973 · 1
R21$431,298 · 1
Top collaborators
- Mark W Grinstaff7 shared
- Ara Nazarian7 shared
- Robert L Sheridan4 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Ara Nazarian$6,376,453
- Satvinder Kaur$1,883,920
- Seward B Rutkove$22,235,643
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyIn VivoOperative Surgical ProceduresRattusSiteCaringTraumaBaseDesignSafetyIn Vivo ModelPainInjuryDebridementMechanicsHourGenerationsHydrogelsAnimalsInjuredIn VitroAdhesivesFamily SuidaeInfection
Grant awards (7)
Relaxin-2 as a Novel Protein Therapeutic for the Treatment of Shoulder Arthrofibrosis$575,973
R56 · FY2020 · AR
Dissolvable Hydrogel Dressing for the Treatment of Burns$381,780
R01 · FY2019 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$381,569
R01 · FY2018 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$379,126
R01 · FY2017 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$391,814
R01 · FY2016 · EB
A Portable Wound Hemostasis System Using a Hydrogel Polymeric Foam$224,130
R21 · FY2013 · EB
A Portable Wound Hemostasis System Using a Hydrogel Polymeric Foam$207,168
R21 · FY2012 · EB